Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 1/2 1

Status

Recruiting 6Active not recruiting 6Terminated 3Completed 3Unknown 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 3Genitourinary 2Gastrointestinal 2

Conditions

Sarcoma 2Neoplasm Metastasis 2Stomach Neoplasms 1Prostatic Neoplasms 1Osteosarcoma 1Colorectal Neoplasms 1Castration-resistant Prostate Cancer 1Bone Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Metastasectomy × Clear all
NCT03965234 2026-03-17

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Roswell Park Cancer Institute

Phase 1/2 Recruiting
99 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Sarcoma, Colorectal Neoplasms

NCT06815666 2026-03-04

BAL Fluid Biomarkers in Sarcoma

University Health Network, Toronto

Phase 2 Recruiting
70 enrolled
Sarcoma

Sarcoma

NCT06585007 2024-09-05

MEDCARE

Universitaire Ziekenhuizen KU Leuven

Phase 3 Recruiting
246 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT05352178 2024-07-03

SPARKLE

Universitaire Ziekenhuizen KU Leuven

Phase 3 Recruiting
873 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06121700 2023-11-08

Miracle-G

Fudan University

Phase 2 Recruiting
55 enrolled
Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Stomach Neoplasms

NCT06114225 2023-11-02

PROMIS

Ruijin Hospital

Phase 2 Recruiting
43 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡